Katz J S, Wolfe G I, Bryan W W, Tintner R, Barohn R J
Department of Neurology, University of Texas, Southwestern Medical Center, Dallas 75235-8897, USA.
Neurology. 1998 Feb;50(2):470-5. doi: 10.1212/wnl.50.2.470.
Two patients were initially diagnosed with myasthenia gravis with elevated titers of acetylcholine receptor antibodies. Features including weakness that normalized with sustained contraction, areflexia, autonomic symptoms, and low-amplitude baseline compound muscle action potentials with abnormal increments following brief exercise and high-frequency repetitive stimulation, however, suggested that these patients had Lambert-Eaton myasthenic syndrome. One patient had antibodies directed against presynaptic calcium channels, confirming the diagnosis. The second patient was seronegative for these antibodies but had elevated titers of antistriated muscle antibodies. This shows that serologic studies can conflict with clinical and electrodiagnostic findings in patients with Lambert-Eaton syndrome. These cases also point out that acetylcholine receptor antibodies are not necessarily diagnostic of myasthenia gravis in patients with Lambert-Eaton syndrome. Instead, these antibodies could represent a nonpathogenic epiphenomenon.
两名患者最初被诊断为重症肌无力,乙酰胆碱受体抗体滴度升高。然而,包括持续收缩后肌无力症状缓解、无反射、自主神经症状以及基线复合肌肉动作电位波幅低,在短暂运动和高频重复刺激后增量异常等特征,提示这些患者患有兰伯特-伊顿肌无力综合征。一名患者存在针对突触前钙通道的抗体,确诊了该诊断。第二名患者这些抗体血清学检测呈阴性,但抗横纹肌抗体滴度升高。这表明在兰伯特-伊顿综合征患者中,血清学研究结果可能与临床和电诊断结果相矛盾。这些病例还指出,在兰伯特-伊顿综合征患者中,乙酰胆碱受体抗体不一定能诊断重症肌无力。相反,这些抗体可能代表一种非致病性的附带现象。